Segment Information by Division

For the Period January 1 to December 31

  download table

2011

€ million

 

Silicones

 

Polymers

 

Biosolutions

 

Polysilicon

 

Siltronic

 

Other

 

Con-
solidation

 

Group

1

Intangible assets; property, plant and equipment; investment property

2

Investments in joint ventures and associates, financial assets

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators. See Note 22

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

External sales

 

1,580.2

 

901.4

 

138.9

 

1,234.8

 

985.1

 

69.3

 

 

4,909.7

Internal sales

 

13.6

 

26.7

 

5.6

 

212.9

 

7.0

 

107.6

 

-373.4

 

Total sales

 

1,593.8

 

928.1

 

144.5

 

1,447.7

 

992.1

 

176.9

 

-373.4

 

4,909.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

103.3

 

76.2

 

13.3

 

545.6

 

-56.7

 

-78.9

 

0.4

 

603.2

Write-downs and impairments/
write-ups of noncurrent assets

 

79.6

 

35.6

 

7.1

 

201.7

 

105.9

 

71.1

 

 

501.0

EBITDA

 

182.9

 

111.8

 

20.4

 

747.3

 

49.2

 

-7.8

 

0.4

 

1,104.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT includes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from investments in joint ventures and associates

 

16.7

 

 

 

 

-24.4

 

 

 

-7.7

Impairment losses

 

 

 

-0.7

 

-25.9

 

-14.8

 

 

 

-41.4

Additions to property, plant and equipment1

 

87.9

 

30.4

 

8.6

 

566.5

 

93.2

 

141.3

 

 

927.9

Additions to financial assets2

 

18.4

 

 

 

 

34.9

 

 

 

53.3

Asset additions

 

106.3

 

30.4

 

8.6

 

566.5

 

128.1

 

141.3

 

 

981.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Dec. 31)

 

1,197.7

 

478.9

 

96.1

 

1,928.7

 

1,190.4

 

1,672.0

 

-326.8

 

6,237.0

Liabilities (Dec. 31)

 

597.9

 

209.1

 

39.8

 

1,796.4

 

317.3

 

965.5

 

-318.7

 

3,607.3

Net assets (Dec. 31)

 

599.8

 

269.8

 

56.3

 

132.3

 

873.1

 

706.5

 

-8.1

 

2,629.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments in joint ventures and associates included in net assets (Dec. 31)

 

80.0

 

 

 

 

44.5

 

 

 

124.5

Research and development expenses

 

-25.4

 

-14.1

 

-6.2

 

-14.5

 

-71.7

 

-42.8

 

1.8

 

-172.9

Employees (Dec. 31)

 

3,956

 

1,412

 

354

 

2,251

 

4,974

 

4,221

 

 

17,168

Employees (average)

 

3,957

 

1,404

 

357

 

2,054

 

5,002

 

4,160

 

 

16,934





  download table

2010

€ million

 

Silicones

 

Polymers

 

Biosolutions

 

Polysilicon

 

Siltronic

 

Other

 

Con-
solidation

 

Group

1

Intangible assets; property, plant and equipment; investment property

2

Investments in joint ventures and associates, financial assets

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators. See Note 22

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

External sales

 

1,563.3

 

788.9

 

138.0

 

1,177.5

 

1,018.7

 

62.0

 

 

4,748.4

Internal sales

 

17.2

 

21.1

 

4.4

 

191.2

 

6.1

 

95.1

 

-335.1

 

Total sales

 

1,580.5

 

810.0

 

142.4

 

1,368.7

 

1,024.8

 

157.1

 

-335.1

 

4,748.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

150.0

 

82.2

 

16.6

 

586.7

 

-3.5

 

-65.5

 

-1.9

 

764.6

Write-downs and impairments/
write-ups of noncurrent assets

 

79.9

 

40.4

 

8.4

 

146.7

 

91.2

 

63.3

 

 

429.9

EBITDA

 

229.9

 

122.6

 

25.0

 

733.4

 

87.7

 

-2.2

 

-1.9

 

1,194.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT includes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from investments in joint ventures and associates

 

-14.1

 

 

 

 

-24.0

 

0.1

 

 

-38.0

Impairment losses

 

-7.5

 

-3.5

 

-1.4

 

 

-0.3

 

 

 

-12.7

Additions to property, plant and equipment1

 

92.1

 

13.1

 

6.5

 

309.9

 

63.8

 

115.4

 

 

600.8

Additions to financial assets2

 

0.8

 

 

 

 

11.7

 

0.6

 

 

13.1

Asset additions

 

92.9

 

13.1

 

6.5

 

309.9

 

75.5

 

116.0

 

 

613.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisitions

 

81.2

 

 

 

 

 

 

 

81.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Dec. 31)

 

1,084.7

 

413.1

 

91.8

 

1,476.6

 

1,237.2

 

1,542.0

 

-344.2

 

5,501.2

Liabilities (Dec. 31)

 

524.5

 

172.9

 

36.9

 

1,391.0

 

293.9

 

976.1

 

-340.9

 

3,054.4

Net assets (Dec. 31)

 

560.2

 

240.2

 

54.9

 

85.6

 

943.3

 

565.9

 

-3.3

 

2,446.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments in joint ventures and associates included in net assets (Dec. 31)

 

42.7

 

 

 

 

69.0

 

 

 

111.7

Research and development expenses

 

-25.3

 

-14.0

 

-3.5

 

-12.8

 

-72.3

 

-39.3

 

2.1

 

-165.1

Employees (Dec. 31)

 

3,892

 

1,377

 

363

 

1,763

 

5,025

 

3,894

 

 

16,314

Employees (average)

 

3,737

 

1,369

 

354

 

1,715

 

5,024

 

3,834

 

 

16,033